|
1)
Lung cancer proteomics: recent advances in
biomarker discovery.
Indovina P*, Marcelli E*, Maranta P, Tarro G.
Int J Proteomics.
2011;2011:726869. Epub 2011 Sep 15.
2)
Antitumor activity of new pyrazolo[3,4-d]pyrimidine
SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement
by WEE1 inhibition.
Cozzi
M, Giorgi F, Marcelli E, Pentimalli F, Forte IM, Schenone S, D'urso
V, De Falco G, Botta M, Giordano A, Indovina P.
Cell Cycle.
2012 Mar 1;11(5). [Epub ahead of print]
3)
Emerging roles of RB family: New defense
mechanisms against tumor progression.
Indovina P, Marcelli E, Casini N, Rizzo V,
Giordano A.
J Cell
Physiol. 2013 Mar
4)
Mass spectrometry-based proteomics: The road to
lung cancer biomarker discovery.
Indovina P, Marcelli E, Pentimalli F,
Tanganelli P, Tarro G, Giordano A.
Mass Spectrom
Rev. 2012 Jul 24
|